Table of Contents As filed with the Securities and Exchange Commission on July 19, 2024. Registration No. 333-280074 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CNS Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2834 82-2318545 (I.R.S. Employer I ...

Table of Contents As filed with the Securities and Exchange Commission on July 12, 2024. Registration No. 333-________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (I.R.S. Employer Identification No.) 2100 West Loop South, Suite 900 Houston, Texas 77027 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CNS Pharmaceuticals, Inc. (Exact Name of Registr ...